, the in-vitro-diagnostics (IVD) market was estimated at a global value of around $61.22 billion, with companies: Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Johnson & Johnson Medical Devices and Diagnostics, Beckman Coulter and BioMerieux. Many of the companies sell capital equipment and supply consumables, and the devices are also used for industrial purposes such as food testing. Molecular diagnostics is estimated at 10% of total revenue, and half of that focused on infectious disease testing. Blood transfusion diagnostics has become increasingly important with the prevalence of infectious and chronic diseases, with companies like: Grifols S.A., Bio-Rad Laboratories, Inc., Quotient Limited, and Immucor, Inc.